Outcomes of second-line axicabtagene ciloleucel for large B-cell lymphoma in the UK.

Saved in:
Bibliographic Details
Title: Outcomes of second-line axicabtagene ciloleucel for large B-cell lymphoma in the UK.
Authors: Kuhnl A; King's College Hospital London UK., Kirkwood AA; CR UK & UCL Cancer Trials Centre, UCL Cancer Institute, UCL London UK., Northend M; University College London Hospitals London UK., Besley C; University Hospitals Bristol and Weston Bristol UK., Uttenthal B; Cambridge University Hospitals Cambridge UK., Norman J; Manchester Royal Infirmary Manchester UK., Hiew H; University Hospital Southampton Southampton UK., Seymour F; Leeds Teaching Hospitals Leeds UK., Maybury B; University Hospital Birmingham Birmingham UK., Osborne W; Freeman Hospital, Newcastle University Newcastle UK., Sillito F; Royal Marsden Hospital London UK., Abdulgawad A; The Christie Hospital Manchester UK., Jones C; University Hospital of Wales Cardiff UK., McCarthy P; Sheffield Teaching Hospital Sheffield UK., Panopoulou A; Oxford University Hospitals Oxford UK., Gribben JG; Barts Cancer Institute Queen Mary University of London London UK., Bataillard E; Imperial College Healthcare NHS Trust London UK., Martinez-Calle N; Nottingham University Hospital Nottingham UK., Gajendran L; St George's University Hospital London UK., O'Reilly M; University College London Hospitals London UK., Kumar E; King's College Hospital London UK., Wilson RP; University Hospitals Bristol and Weston Bristol UK., Kasivisvanathan S; Cambridge University Hospitals Cambridge UK., Fadlelmula N; Manchester Royal Infirmary Manchester UK., Pryce A; University Hospital Southampton Southampton UK., Awofisayo O; Leeds Teaching Hospitals Leeds UK., Maraj A; King's College Hospital London UK., Townsend W; University College London Hospitals London UK., Cwynarski K; University College London Hospitals London UK., Paneesha S; University Hospital Birmingham Birmingham UK., Mathew A; University Hospital Birmingham Birmingham UK., Dulobdas V; University Hospital Birmingham Birmingham UK., El-Sharkawi D; Royal Marsden Hospital London UK., Creasey T; Freeman Hospital, Newcastle University Newcastle UK., Warren M; University Hospital of Wales Cardiff UK., Malladi R; Cambridge University Hospitals Cambridge UK., Owen M; Leeds Teaching Hospitals Leeds UK., Waraich M; Manchester Royal Infirmary Manchester UK., Ediriwickrema K; Oxford University Hospitals Oxford UK., Froggatt J; The Christie Hospital Manchester UK., Delaney A; Sheffield Teaching Hospital Sheffield UK., Davies AJ; University Hospital Southampton Southampton UK., Alajangi R; University Hospitals Bristol and Weston Bristol UK., Collins GP; Oxford University Hospitals Oxford UK., Sanderson R; King's College Hospital London UK., Roddie C; University College London Hospitals London UK., Menne T; Freeman Hospital, Newcastle University Newcastle UK., Chaganti S; University Hospital Birmingham Birmingham UK.
Source: HemaSphere [Hemasphere] 2026 Feb 19; Vol. 10 (2), pp. e70312. Date of Electronic Publication: 2026 Feb 19 (Print Publication: 2026).
Publication Type: Journal Article
Journal Info: Publisher: Wiley Country of Publication: United States NLM ID: 101740619 Publication Model: eCollection Cited Medium: Internet ISSN: 2572-9241 (Electronic) Linking ISSN: 25729241 NLM ISO Abbreviation: Hemasphere Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:2572-9241
DOI:10.1002/hem3.70312